Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,450,857
- Total 13F shares
- 12,761,893
- Share change
- +2,208
- Total reported value
- $410,350,129
- Price per share
- $32.23
- Number of holders
- 41
- Value change
- -$213,790
- Number of buys
- 16
- Number of sells
- 16
Quarterly Holders Quick Answers
What is CUSIP 87650L103?
CUSIP 87650L103 identifies TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87650L103:
Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
|
Company |
7.6%
|
3,245,035
|
$134,117,000 | — | 31 Dec 2020 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
5.8%
|
2,463,601
|
$98,987,000 | — | 31 Dec 2020 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
4.5%
|
1,917,157
|
$79,236,000 | — | 31 Dec 2020 | |
| Cormorant Asset Management, LP |
13F
|
Company |
4%
|
1,714,269
|
$69,965,000 | — | 31 Dec 2020 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.1%
|
1,296,416
|
$53,580,000 | — | 31 Dec 2020 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
1.1%
|
464,600
|
$19,202,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.76%
|
322,423
|
$13,326,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.64%
|
270,891
|
$11,197,000 | — | 31 Dec 2020 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
260,000
|
$10,746,000 | — | 31 Dec 2020 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.47%
|
200,000
|
$8,266,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.34%
|
144,236
|
$5,961,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.26%
|
110,375
|
$4,561,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.23%
|
96,884
|
$4,004,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
70,399
|
$2,909,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.09%
|
37,223
|
$1,539,000 | — | 31 Dec 2020 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.05%
|
20,000
|
$827,000 | — | 31 Dec 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.05%
|
19,367
|
$801,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
18,417
|
$761,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.04%
|
16,783
|
$694,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.02%
|
10,088
|
$417,000 | — | 31 Dec 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
9,299
|
$384,000 | — | 31 Dec 2020 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
8,600
|
$355,000 | — | 31 Dec 2020 | |
| Hunter Perkins Capital Management, LLC |
13F
|
Company |
0.02%
|
8,000
|
$331,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
6,372
|
$263,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
4,314
|
$178,000 | — | 31 Dec 2020 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
3,574
|
$148,000 | — | 31 Dec 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
3,500
|
$145,000 | — | 31 Dec 2020 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
3,250
|
$134,323 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
3,193
|
$132,000 | — | 31 Dec 2020 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0.01%
|
2,271
|
$93,860 | — | 31 Dec 2020 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,500
|
$61,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,483
|
$61,000 | — | 31 Dec 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,325
|
$55,000 | — | 31 Dec 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,151
|
$48,000 | — | 31 Dec 2020 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
965
|
$43,000 | — | 31 Dec 2020 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
825
|
$34,000 | — | 31 Dec 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
645
|
$27,000 | — | 31 Dec 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
639
|
$27,000 | — | 31 Dec 2020 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
515
|
$21,000 | — | 31 Dec 2020 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
18
|
$1,000 | — | 31 Dec 2020 |
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q1 2021
As of 31 Mar 2021,
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,761,893 shares.
The largest 10 holders included
Vivo Capital, LLC, RTW INVESTMENTS, LP, FRAZIER MANAGEMENT LLC, Cormorant Asset Management, LP, PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, BlackRock Inc., VANGUARD GROUP INC, SANDS CAPITAL MANAGEMENT, LLC, and Ensign Peak Advisors, Inc.
This page lists
41
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
39
Q1 2021 holders
41
Holder diff
2
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.